MNTA - Momenta Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.68. This is a potential upside of $6.68 (0%) from yesterday's end of day stock price of $0.

Momenta Pharmaceuticals's activity chart (see below) currently has 56 price targets and 35 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 94.7% with an average time for these price targets to be met of 289.55 days.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 25-Aug-2020. First documented stock forecast 08-Jan-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$50

4 years 2 months 27 days ago
(25-Aug-2020)

11/11 (100%)

$19.95 (66.39%)

190

Hold

$45

4 years 2 months 28 days ago
(24-Aug-2020)

7/7 (100%)

$20.74 (85.49%)

287

Hold

$42

$-10.48 (-19.97%)

$42

4 years 3 months 2 days ago
(19-Aug-2020)

3/4 (75%)

$-10.12 (-19.42%)

27

Buy

$47

$-5.48 (-10.44%)

$43

4 years 3 months 11 days ago
(10-Aug-2020)

5/5 (100%)

$18.45 (64.62%)

320

Buy

$20

4 years 3 months 18 days ago
(03-Aug-2020)

5/5 (100%)

$1.18 (8.57%)

246

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MNTA (Momenta Pharmaceuticals) average time for price targets to be met?

On average it took 289.55 days on average for the stock forecasts to be realized with a an average price target met ratio 94.7

Which analyst has the current highest performing score on MNTA (Momenta Pharmaceuticals) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on MNTA (Momenta Pharmaceuticals)?

Danielle Brill works at RAYMOND JAMES and has 8 price targets and 6 ratings on MNTA

Which analyst is the currently most bullish on MNTA (Momenta Pharmaceuticals)?

Robyn Karnauskas with highest potential upside - $4.52

Which analyst is the currently most reserved on MNTA (Momenta Pharmaceuticals)?

Difei Yang with lowest potential downside - -$35.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?